Search Results - "COHEN, P. D"

Refine Results
  1. 1

    Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC by Ou, S.-H. I., Jänne, P.A., Bartlett, C.H., Tang, Y., Kim, D.-W., Otterson, G.A., Crinò, L., Selaru, P., Cohen, D.P., Clark, J.W., Riely, G.J.

    Published in Annals of oncology (01-02-2014)
    “…Crizotinib is approved to treat advanced ALK-positive non-small-cell lung cancer (NSCLC), but most patients ultimately develop progressive disease (PD). We…”
    Get full text
    Journal Article
  2. 2

    Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib by George, S., Reichardt, P., Lechner, T., Li, S., Cohen, D.P., Demetri, G.D.

    Published in Annals of oncology (01-12-2012)
    “…Reliable biomarkers of sunitinib response in gastrointestinal stromal tumor (GIST) are lacking. Hypertension (HTN), an on-target class effect of vascular…”
    Get full text
    Journal Article
  3. 3

    Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure by George, S, Blay, J.Y, Casali, P.G, Le Cesne, A, Stephenson, P, DePrimo, S.E, Harmon, C.S, Law, C.N.J, Morgan, J.A, Ray-Coquard, I, Tassell, V, Cohen, D.P, Demetri, G.D

    Published in European journal of cancer (1990) (01-07-2009)
    “…Abstract Aims To assess the antitumour activity, safety, pharmacokinetics and pharmacodynamics of continuous daily sunitinib dosing in patients with…”
    Get full text
    Journal Article
  4. 4

    The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism by PRESSLEY, J. C, LOUIS, E. D, TANG, M.-X, COTE, L, COHEN, P. D, GLIED, S, MAYEUX, R

    Published in Neurology (14-01-2003)
    “…Persons with parkinsonism have high rates of both associated and unrelated prevalent comorbid conditions. A better understanding of patterns of care and…”
    Get full text
    Journal Article
  5. 5

    Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib by Selaru, P, Tang, Y, Huang, B, Polli, A, Wilner, KD, Donnelly, E, Cohen, DP

    Published in Clinical and translational science (01-04-2016)
    “…In order to demonstrate a statistically significant and clinically meaningful benefit of one therapy over another, these trials generally enrolled large…”
    Get full text
    Journal Article
  6. 6

    Understanding the Fe i Line Measurements Returned by the Helioseismic and Magnetic Imager (HMI) by Cohen, D. P., Criscuoli, S., Farris, L., Tritschler, A.

    Published in Solar physics (01-03-2015)
    “…The Helioseismic and Magnetic Imager (HMI) onboard the Solar Dynamics Observatory (SDO) observes the Sun at the Fe i 6173 Å line and returns full-disk maps of…”
    Get full text
    Journal Article
  7. 7

    The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure by Layman, L C, Amde, S, Cohen, D P, Jin, M, Xie, J

    Published in Fertility and sterility (01-02-1998)
    “…To determine whether FSH receptor gene missense mutation in Finnish women with premature ovarian failure (POF) is present in North American women with POF…”
    Get more information
    Journal Article
  8. 8

    Comparative cannabis use data by Abraham, M D, Cohen, P D, Beukenhorst, D J

    Published in British journal of psychiatry (01-08-2001)
    “…[...]MacCoun & Reuter state that the lifetime prevalence of cannabis in The Netherlands has increased consistently and sharply in the age group 18-20, stating:…”
    Get full text
    Journal Article
  9. 9

    Molecular evaluation of the gonadotropin-releasing hormone receptor by Cohen, D P

    Published in Seminars in reproductive medicine (2000)
    “…The gonadotropin-releasing hormone receptor (GnRHR) is a guanine nucleotide-binding protein-coupled receptor with a characteristic seven transmembrane domain…”
    Get more information
    Journal Article
  10. 10

    Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome by Cohen, D P, Stein, E M, Li, Z, Matulis, C K, Ehrmann, D A, Layman, L C

    Published in Fertility and sterility (01-08-1999)
    “…To determine whether a mutation in the GnRH receptor gene is responsible for polycystic ovary syndrome (PCOS). Molecular analysis of human genomic DNA…”
    Get more information
    Journal Article
  11. 11

    Vesicular transport of myelin proteolipid and cerebroside sulfates to the myelin membrane by Brown, M C, Besio Moreno, M, Bongarzone, E R, Cohen, P D, Soto, E F, Pasquini, J M

    Published in Journal of neuroscience research (01-07-1993)
    “…The possibility that cerebroside sulfates and myelin proteolipid (PLP) could be simultaneously located in transport vesicles destined to be assembled in myelin…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism by Layman, Lawrence C, Cohen, David P, Jin, Mei, Xie, Jun, Li, Zhu, Reindollar, Richard H, Bolbolan, Shahla, Bick, David P, Sherins, Richard R, Duck, L. Wayne, Musgrove, Lois C, Sellers, Jeffrey C, Neill, Jimmy D

    Published in Nature genetics (01-01-1998)
    “…Idiopathic hypogonadotropic hypogonadism (IHH) is one of the most common causes of hereditary hypogonadism. Affected males and females present with…”
    Get full text
    Journal Article
  14. 14

    Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells by Cohen, DP, Rothstein, TL

    Published in The Journal of immunology (1950) (01-05-1991)
    “…Conventional murine splenic B cells are stimulated to initiate DNA synthesis by the combination of a phorbol ester protein kinase C (PKC) agonist, and a…”
    Get full text
    Journal Article
  15. 15

    Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes by Cohen, Darrel P, Adams, David J, Flowers, James L, Wall, Monroe E, Wani, Mansukh C, Manikumar, G, Colvin, O.Michael, Silber, Robert

    Published in Leukemia research (01-11-1999)
    “…The topoisomerase I inhibitor camptothecin and its analogs have potent activity against a wide range of solid tumors and several hematologic malignancies…”
    Get full text
    Journal Article
  16. 16

    Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib by RINI, Brian I, COHEN, Darrel P, LU, Dongrui R, CHEN, Isan, HARIHARAN, Subramanian, GORE, Martin E, FIGLIN, Robert A, BAUM, Michael S, MOTZER, Robert J

    “…Hypertension (HTN) is an on-target effect of the vascular endothelial growth factor pathway inhibitor, sunitinib. We evaluated the association of…”
    Get full text
    Journal Article
  17. 17

    TEMPORAL CORRELATIONS BETWEEN OPTICAL AND GAMMA-RAY ACTIVITY IN BLAZARS by Cohen, Daniel P, Romani, Roger W, Filippenko, Alexei V, Cenko, S Bradley, Lott, Benoit, Zheng, Kang, Li, Weidong

    Published in The Astrophysical journal (08-12-2014)
    “…We have been using the 0.76 m Katzman Automatic Imaging Telescope (KAIT) at Lick Observatory to optically monitor a sample of 157 blazars that are bright in…”
    Get full text
    Journal Article
  18. 18

    Induction of phorbol ester responsiveness in conventional B cells after activation via surface Ig by Rothstein, TL, Kolber, DL, Murphy, TP, Cohen, DP

    Published in The Journal of immunology (1950) (01-12-1991)
    “…The signals required to induce S phase entry in murine splenic B cells were found to be altered by prolonged treatment with low doses of anti-Ig antibody…”
    Get full text
    Journal Article
  19. 19

    Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals by Layman, L C, McDonough, P G, Cohen, D P, Maddox, M, Tho, S P, Reindollar, R H

    Published in Fertility and sterility (01-06-2001)
    “…To characterize the phenotype of idiopathic hypogonadotropic hypogonadism due to compound heterozygous GnRHR gene mutations (Arg262Gln/Tyr284Cys)…”
    Get more information
    Journal Article
  20. 20

    The shortest path is not the one you know: application of biological network resources in precision oncology research by Kuperstein, Inna, Grieco, Luca, Cohen, David P A, Thieffry, Denis, Zinovyev, Andrei, Barillot, Emmanuel

    Published in Mutagenesis (01-03-2015)
    “…Several decades of molecular biology research have delivered a wealth of detailed descriptions of molecular interactions in normal and tumour cells. This…”
    Get full text
    Journal Article